Sara Hedfors Vidlin

Years Active: 2020-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Oskar Gauffin, Judith S Brand, Sara Hedfors Vidlin, Daniele Sartori, Suvi Asikainen, Martí Català, Etir Chalabi, Daniel Dedman, Ana Danilovic, Talita Duarte-Salles, Maria Teresa García Morales, Saara Hiltunen, Annika M Jödicke, Milan Lazarevic, Miguel A Mayer, Jelena Miladinovic, Joseph Mitchell, Andrea Pistillo, Juan Manuel Ramírez-Anguita, Carlen Reyes, Annette Rudolph, Lovisa Sandberg, Ruth Savage, Martijn Schuemie, Dimitrije Spasic, Nhung T H Trinh, Nevena Veljkovic, Ankica Vujovic, Marcel de Wilde, Alem Zekarias, Peter Rijnbeek, Patrick Ryan, Daniel Prieto-Alhambra, G Niklas Norén
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study. Drug safety (2023)
Sara Hult, Daniele Sartori, Tomas Bergvall, Sara Hedfors Vidlin, Birgitta Grundmark, Johan Ellenius, G Niklas Norén
A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance. Drug safety 43 (8) (2021)
Alem Zekarias, Sarah Watson, Sara Hedfors Vidlin, Birgitta Grundmark
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports. Drug safety 43 (12) (2020)

Sara Hedfors Vidlin.css-eqlu8i{font-size:small;padding-left:4px;}